video length: 4:49
September 8, 2018
video length: 4:49
In looking ahead to the Q3 earnings season here are the key points: Total earnings for the S&P 500 index are expected to be up +18.1% in Q3 from the same period last year on +7.2% higher revenues, the 6th time
Two weeks ago I laid out the potential pathways for the market suggesting that with the markets very oversold a pullback to support was likely. To wit: “While I point out the prevailing risks, and the disconnect between bullish sentiment
Fundamental Forecast for GBP: Bullish STERLING (GBP) TALKING POINTS: Sterling making gains against a range of currencies, but the US dollar remains stubbornly strong. Big week of data releases and the latest Bank of England meeting. The DailyFX Q3 GBP Forecast is available to download.
Stocks fall to the edge of the expected move for the week once again showing how crucial these levels are that we discuss every week. In this crucial weekend video newsletter update we focus on what risks to watch for
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange (see story). Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established. It claims to be one of the top 30 biopharmas in China, with revenues
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange (see story). Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established. It claims to be one of the top 30 biopharmas in China, with revenues
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange (see story). Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established. It claims to be one of the top 30 biopharmas in China, with revenues
